LIFE SPINE ACHIEVES 32% SALES GROWTH AND ANNOUNCES INDUSTRY’S LARGEST POST-PACKING CAPABILITIES FOR LATERAL FUSION
Huntley, IL, October 26, 2016 –
Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today achievement of another astonishing growth milestone, with a sales growth rate of 32% in the third quarter of 2016, as compared to the same quarter in 2015.
Life Spine also announced today industry-leading post-packing capabilities with its e-LIF™ Expandable Lateral Interbody Fusion procedure, which includes the CENTRIC® Expandable Retractor System, the LONGBOW™ Expandable Lateral Interbody System, the SENTRY™ Lateral Plate System and the newly launched Graft Delivery Device. LONGBOW is the first lateral A/P expanding interbody, providing nearly double its width during in-situ expansion. LONGBOW reduces muscle retraction and potential nerve damage, and when LONGBOW is combined with the Graft Delivery Device, which seamlessly integrates with the LONGBOW in-situ, post-pack graft volumes of over 11cc can be delivered.
“We are excited to add another great product to our existing MIS thoracolumbar portfolio. The addition of the Graft Delivery Device has been very well received by surgeons, and the e-LIF procedure has the potential for increased fusion rates and improved patient outcomes,” said Mariusz Knap, Vice President of Marketing at Life Spine.
Life Spine will be displaying its entire product portfolio at the 31st North American Spine Society (NASS) Annual Meeting, taking place this week in Boston, and will be located at Booth #1031.
About Life Spine
Life Spine is dedicated to improving the quality of life for spinal patients by increasing procedural efficiency and efficacy through innovative design, uncompromising quality standards, and the most technologically advanced manufacturing platforms.